Bing Du

Also affiliated with Central South University, New York University Shanghai, Shanghai Medical Information Center, Capital Institute of Pediatrics, Capital Health, East China Normal University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders”.

Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders

Nature Communications(2020)10.1038/s41467-020-18723-y

N/A

0DataRank · unranked

217 citations

Kendra Hoekzema, Davide Vecchio, Huidan Wu, Arvis Sulovari, Bradley P. Coe +95 more

FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma

PLoS Biology(2024)10.1371/journal.pbio.3002621

N/A

0DataRank · unranked

12 citations

Yuxiang Cao, Meiyao Meng, Jin Qiu, Chao Ni, Xiaozhen Guo +13 more

143 | REAL‐WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) FOR THE TREATMENT OF RICHTER TRANSFORMATION TO LARGE B‐CELL LYMPHOMA (RT‐LBCL)

Hematological Oncology(2025)10.1002/hon.70093_143

N/A

0DataRank · unranked

1 citations

Constance Lau, Mazyar Shadman, Alex F. Herrera, Caron A. Jacobson, F. L. Locke +13 more

Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory (R/R) secondary central nervous system lymphoma (SCNSL).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.7024

N/A

0DataRank · unranked

0 citations

Babatunde Adedokun, Hamza Hashmi, Mazyar Shadman, Allison Winter, Alex F. Herrera +14 more